Wire flash
FinanceuniQure reports Q2 2026 financial results, files 10-Q with SEC
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
This is a transcript of uniQure N.V.'s second quarter 2026 earnings call held on July 29, 2026. The call was led by CEO Matthew Kapusta, CFO Christian Klemt, Chief Medical Officer Walid Abi-Saab, and Chief Customer & Strategy Officer Kylie O'Keefe. The company released its Q2 2026 financial results and filed its 10-Q with the SEC. The call includes prepared remarks from executives followed by a question-and-answer session with analysts from Guggenheim, Leerink Partners, Goldman Sachs, Mizuho, TD Cowen, Cantor Fitzgerald, Kempen, H.C. Wainwright, and Wolfe Research. The transcript covers the company's financial performance, strategic updates, and pipeline developments in gene therapy.
Source report
Date: July 29, 2026 Time: 8:30 AM EDT
Company Participants
- Chiara Russo – Senior Director of Investor Relations
- Matthew Kapusta – CEO & Executive Director
- Walid Abi-Saab – Chief Medical Officer
- Kylie O'Keefe – Chief Customer & Strategy Officer
- Christian Klemt – CFO, Principal Financial Officer & GM of Amsterdam Site
Conference Call Participants
- Debjit Chattopadhyay – Guggenheim Securities, LLC, Research Division
- Joseph Schwartz – Leerink Partners LLC, Research Division
- Lydia Erdman – Goldman Sachs Group, Inc., Research Division
- Uy Ear – Mizuho Securities USA LLC, Research Division
- Joseph Thome – TD Cowen, Research Division
- Kristen Kluska – Cantor Fitzgerald & Co., Research Division
- Suzanne van Voorthuizen – Kempen & Co. N.V., Research Division
- Arabella Caroline Ng – H.C. Wainwright & Co, LLC, Research Division
- Guofang Li – Wolfe Research, LLC
Presentation
Operator
Hello, and thank you for standing by. My name is Joy, and I will be your conference operator today. At this time, I would like to welcome everyone to the uniQure Second Quarter 2026 Earnings Call. [Operator Instructions]
I would now like to turn the call over to Chiara Russo, Senior Director of Investor Relations. Please go ahead, ma'am.
Chiara Russo – Senior Director of Investor Relations
Good morning, and thank you for joining us for uniQure's second quarter of 2026 earnings call. Earlier this morning, uniQure released financial results for the second quarter of 2026, and our press release is available on the Investors and Media section of our website at uniqure.com. Our 10-Q was also filed with the SEC earlier today.
Joining me on the call this morning are Matt Kapusta, Chief Executive Officer; Dr. Walid Abi-Saab, Chief Medical Officer; Kylie O'Keefe, Chief Customer and Strategy Officer; and Christian Klemt, our Chief Financial Officer. After our formal remarks, we'll open up the call for Q&A.
Before we begin, please note that we...
Source
All Articles on Seeking AlphaNeutral / independent
Part of this Story
uniQure N.V. Q2 2026 Earnings Call Transcript